Spirometry assessment of interstitial lung disease patients and correlation with its clinical and radiological profile
DOI:
https://doi.org/10.18203/2320-6012.ijrms20223623Keywords:
Interstitial lung disease, Idiopathic pulmonary fibrosis, Spirometry, FEV1/FVC, HRCT chestAbstract
Background: Interstitial lung diseases (ILD) are a diverse set of lower respiratory tract illnesses that are defined by both abrupt and persistent inflammation as well as a largely irreversible and continuous progression of fibrosis in the interstitium and the walls of the alveoli. This study focuses on non-invasive techniques for clinically and radiographically confirmed situations. Since most patients refuse surgical or transbronchial lung biopsies and are in respiratory difficulty, an alternate method is preferable. Spirometry tests are often used as diagnostic aids. This study compares spirometry in ILD patients with their radiological and clinical features.
Methods: In this prospective observational study, 50 ILD patients who were diagnosed on the clinical and radiological grounds included. A detailed history of illness was obtained and noted. All patients were examined clinically and underwent basic investigations. All patients were performed 6 MWT O2 saturation and spirometry. Correlation between spirometry findings and clinical and radiological profile was done.
Results: The study group of 50 patients with ILD, idiopathic pulmonary fibrosis was the most common cause of ILD consists of 32 patients performing 64% of the study group. Average duration of symptoms in ILD patients in this study was 5.46±5.49 months. The mean age of the patients was 61.58±12.92 years ranging from 27 to 88 years with 27 (54%) male and 23 (46%) female. Cough and dyspnoea were the most common features at presentation in our study group, present in almost all the patients. Crepitations were present in 41 (82%) patients. Most common chest X-ray feature was reticular opacities which was present in 24 (48%) patients. Ground glass opacity in high-resolution computed tomography (HRCT) was seen in 33 (66%) patients. Most common spirometry pattern seen in our study was Restrictive pattern which was present in 42 patients. In ILD patients, mean values of FEV1% was 59.2±20.33, FVC% was 60.76±25.45, FEV1/FVC was 100.86±20.12.
Conclusions: Idiopathic pulmonary fibrosis is the most common and chronic hypersensitivity pneumonitis along with cryptogenic organizing pneumonia are the second common ILD in our study. The underdiagnosis of interstitial lung disease is due to a lack of knowledge among doctors. Therefore, spirometry and 6MWT O2 saturation should be performed in all patients presented with complaints of chronic cough and breathlessness as screening tool and then HRCT chest and biopsy can be done for confirmation of diagnosis. So early diagnosis and treatment of ILD patients is possible with use of spirometry.
Metrics
References
Strange C. Interstitial lung disease in the patient who has connective tissue disease. Clinic Chest Med. 2004;549:559.
Coultas DB. Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150:967-72.
Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of interstitial lung diseases. Mayo Clin Proc. 2007;82:976-86.
Society ER. American Thoracic Society: American Thoracic Society. Am Resp Crit Care Med. 2002;15:277-304.
Rivera-Ortega P, Molina-Molina M. Interstitial lung diseases in developing countries. Ann Global Health. 2019;85(1):4.
Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1990;141:169-202.
Bolliger CT, Mathur PN, Beamis JF, Becker HD, Cavaliere S: Colt H, Diaz-Jimenez JP, Dumon JF, Edell E, Kovitz KL, Macha HN. ERS/ATS statement on interventional pulmonology. European respiratory society/american thoracic society. Eur Resp J. 2002;19:356-73.
Simon MR, Chinchilli VM, Phillips BR, Sorkness CA, Lemanske RF Jr, Szefler SJ, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allerg Clin Immunol. 2010;126:527-34.
Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, et al. Interstitial Lung Disease in India. Results of a Prospective Registry. Am J Respir Crit Care Med. 2017;195:801-13.
Sreekala C, Soofia M, Nair S, Kumari KA. Interstitial lung diseases - a tertiary care center experience. Int J Med Res Rev. 2017;5:657-63.
Rai DK, Kumar A, Kumar S, Thakur S, Kumar R. Clinical Profile of Interstitial Lung Disease at a Tertiary Care Centre in India. Indian J Chest Dis Allied Sci. 2021;63(1).
Jafri S, Ahmed N, Saifullah N, Musheer M. Epidemiology and Clinico-radiological features of Interstitial Lung Diseases. Pak J Med Sci. 2020;36:365-70.
Agrawal N. Study of Clinico-Radiological Profile of Interstitial Lung Disease Patients Attending Crgh Ujjain: Int J Med Sci Diagnosis Res. 2019;28:3.
Mahashur AA, Dave KM, Kinare SG, Kamat SR, Shetye VM, Kolhatkar VP. Diffuse fibrosing alveolitis-an Indian experience. Lung India. 19831;1:171-9.
Gagiya AK, Suthar HN, Bhagat GR. Clinical profile of interstitial lung diseases cases. Natl J Med Res. 2012;2:2-4.
Kumar A, Yadav P, Gupta KA, Gautam KA, Kumar A. Profile of interstitial lung diseases at tertiary care centre of northern India. Eur J Pharm Med Res. 2016:368-74.
Kumar R, Gupta N, Goel N. Spectrum of interstitial lung disease at a tertiary care centre in India. 2014;82:218-26.
Jindal SK, Malik SK, Deodhar SD, Sharma BK. Fibrosing alveolitis: a report of 61 cases seen over the past five years. Indian J Chest Dis Allied Sci. 1979;21(4):174-9.
Subhash HS, Ashwin I, Solomon SK, David T, Cherian AM, Thomas K. A comparative study on idiopathic pulmonary fibrosis and secondary diffuse parenchymal lung disease. Indian J Med Sci. 2004;58(5):185-90.
Tiwari A, Kumar K, Bhushan B, Kajal NC, Gupta S, Singh D. Study of clinic radiological profile and treatment modalities in interstitial lung disease. Sch J App Med Sci. 2016;4:1086-105.
Sen T, Udwadi ZF. Retrospective Study of Interstitial Lung Disease in a Tertiary Care Centre in India. Indian J Chest Dis Allied Sci. 2010;52:207-11.
Dhooria S, Agarwal R, Sehgal IS, Prasad KT, Garg M, Bal A, et al. Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects. PloS One. 2018;13(2):e0191938.
Kundu S, Mitra S, Ganguly J, Mukherjee S, Ray S, Mitra R. Spectrum of diffuse parenchymal lung diseases with special reference to idiopathic pulmonary fibrosis and connective tissue disease: An eastern India experience. Lung India. 2014;31:354-60.
Mahesh NS, Sadanand CD, Lawande D. Clinical Profile of Idiopathic Pulmonary Fibrosis. Acad J Med. 2019;2:86-9.
Flaherty KR, Mumford JA, Murray S., Kazerooni EA, Gross BH, Colby TV, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168:543-8.
Jankharia GR. Commentary - radiology in India: the next decade. Indian J Radiol Imaging. 2008;18:189-91.
Patil PB, Kawade D, Titare P, Kaginalkar VR. HRCT Assessment of interstitial lung diseases. Int J Contemp Med Res. 2016;3:2426-30.